A Mutation Is Making It Easier for Drug-Resistant Malaria to Spread

Researchers identified a genetic mutation in malaria parasites that reduces the effectiveness of artemisinin, a primary antimalarial drug. The mutation alters a protein in the parasite, allowing it to survive exposure to artemisinin at concentrations that would normally kill the organism. Studies documented the mutation spreading across malaria-endemic regions in Southeast Asia and Africa. The finding has prompted health officials to monitor treatment resistance patterns and adjust drug protocols accordingly.

Next story